Clinical Trial Update: Intranasal Sufentanil Pain-management at Entrance of Emergency Department : Influence on Pain-relief Delay [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on intranasal sufentanil for pain relief at ED entry in adults with severe traumatic limb injuries; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Sufentanil (intranasal) (sufentanil)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Single Traumatic Limb Injury With Severe Pain (Score > 5/10 on Numerical Pain Scale) | Phase 4 | Status: COMPLETED